This would be Dermata's second patent for DMT410, if issued, using its Spongilla technology to topically deliver botulinum ...

Dermata Therapeutics (DRMA) announced the Australian Patent Office has accepted its patent application for its DMT410 program for the treatment of ...

Lawyers warn that control over who administers Botox, especially those without medical education, is weak, and Botox imports are often untraceable.

A quarter of over 130 people treated in public hospitals last year for suspected “space oil” consumption were under 18 – the ...

Tuna sold in 26 states and in Washington, D.C., was recalled over concerns that it may have been contaminated. The stores ...

The Reverse Stock Split will take legal effect at 12:01 A.M. Eastern Time on February 26, 2025, and the Company's Common Stock will open for trading on the NYSE American on February 26, 2025, on a ...

Certain tuna products may have defective lids that could lead to "a potentially fatal form of food poisoning," FDA notice ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

Injectable botulinum toxin was associated with significant efficacy and sufficient safety outcomes in treating patients with androgenetic alopecia.

Concerns around botulism, a potentially fatal form of food poisoning, are rising after canned tuna sold at popular grocery stores was recalled. But what is the illness and how does it develop?

Korean firms pursue botulinum toxin market amid rising global demand Pharmaceutical companies capitalize on expanding ...

This would be Dermata's second patent for DMT410, if issued, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -- The Company recently entered into a Clinical Trial ...